Search research articles
Contact Us
Filters
Showing results (191-200 of 206) with videos related to
Page
of 21
Sort By:
The Journal of Clinical Investigation
|
July 20, 2018
Specific covalent inhibition of MALT1 paracaspase suppresses B cell lymphoma growth
Lorena Fontán, Qi Qiao, John M Hatcher, et al.
Cell Chemical Biology
|
February 27, 2018
SRPKIN-1: A Covalent SRPK1/2 Inhibitor that Potently Converts VEGF from Pro-angiogenic to Anti-angiogenic Isoform
John M Hatcher, Guowei Wu, Chuyue Zeng, et al.
British Journal of Haematology
|
November 19, 2025
Repurposing pacritinib to target MYD88-mutated Waldenström macroglobulinaemia
Shirong Liu, Amanda Kofides, Xia Liu, et al.
Blood Advances
|
January 16, 2026
Quantitative MYD88L265P and CXCR4S338X analysis to assess clinical trial performance in Waldenstrom Macroglobulinemia
Nickolas Tsakmaklis, Zachary R Hunter, Xia Liu, et al.
Hormones and Behavior
|
June 25, 2024
Treatment with brain specific estrogen prodrug ameliorates cognitive effects of surgical menopause in mice
Abigail E Salinero, Charly Abi-Ghanem, Harini Venkataganesh, et al.
Biorxiv : the Preprint Server for Biology
|
August 23, 2023
Brain Specific Estrogen Ameliorates Cognitive Effects of Surgical Menopause in Mice
Abigail E Salinero, Charly Abi-Ghanem, Harini Venkataganesh, et al.
Cancer Research
|
February 12, 2022
A Novel HER2-Selective Kinase Inhibitor Is Effective in HER2 Mutant and Amplified Non-Small Cell Lung Cancer
Jieun Son, Jaebong Jang, Tyler S Beyett, et al.
Journal of Medicinal Chemistry
|
April 10, 2023
Catalytic Degraders Effectively Address Kinase Site Mutations in EML4-ALK Oncogenic Fusions
Yang Gao, Baishan Jiang, Hellen Kim, et al.
Blood Advances
|
April 15, 2026
Zanubrutinib and pirtobrutinib show synergistic killing and suppression of BTK signaling in MYD88-mutated lymphoma cells
Dominic Pizzarella, Amanda Kofides, John M Hatcher, et al.
Public Health Reports (Washington, D.C. : 1974)
|
July 8, 2020
Trends in Indicators of Injection Drug Use, Indian Health Service, 2010-2014 : A Study of Health Care Encounter Data
Mary E Evans, Marissa Person, Brigg Reilley, et al.
Page
of 21
Search research articles
Search
Showing results (191-200 of 206) with videos related to
Sort By:
Page
of 21
The Journal of Clinical Investigation
|
July 20, 2018
Specific covalent inhibition of MALT1 paracaspase suppresses B cell lymphoma growth
Lorena Fontán, Qi Qiao, John M Hatcher, et al.
Cell Chemical Biology
|
February 27, 2018
SRPKIN-1: A Covalent SRPK1/2 Inhibitor that Potently Converts VEGF from Pro-angiogenic to Anti-angiogenic Isoform
John M Hatcher, Guowei Wu, Chuyue Zeng, et al.
British Journal of Haematology
|
November 19, 2025
Repurposing pacritinib to target MYD88-mutated Waldenström macroglobulinaemia
Shirong Liu, Amanda Kofides, Xia Liu, et al.
Blood Advances
|
January 16, 2026
Quantitative MYD88L265P and CXCR4S338X analysis to assess clinical trial performance in Waldenstrom Macroglobulinemia
Nickolas Tsakmaklis, Zachary R Hunter, Xia Liu, et al.
Hormones and Behavior
|
June 25, 2024
Treatment with brain specific estrogen prodrug ameliorates cognitive effects of surgical menopause in mice
Abigail E Salinero, Charly Abi-Ghanem, Harini Venkataganesh, et al.
Biorxiv : the Preprint Server for Biology
|
August 23, 2023
Brain Specific Estrogen Ameliorates Cognitive Effects of Surgical Menopause in Mice
Abigail E Salinero, Charly Abi-Ghanem, Harini Venkataganesh, et al.
Cancer Research
|
February 12, 2022
A Novel HER2-Selective Kinase Inhibitor Is Effective in HER2 Mutant and Amplified Non-Small Cell Lung Cancer
Jieun Son, Jaebong Jang, Tyler S Beyett, et al.
Journal of Medicinal Chemistry
|
April 10, 2023
Catalytic Degraders Effectively Address Kinase Site Mutations in EML4-ALK Oncogenic Fusions
Yang Gao, Baishan Jiang, Hellen Kim, et al.
Blood Advances
|
April 15, 2026
Zanubrutinib and pirtobrutinib show synergistic killing and suppression of BTK signaling in MYD88-mutated lymphoma cells
Dominic Pizzarella, Amanda Kofides, John M Hatcher, et al.
Public Health Reports (Washington, D.C. : 1974)
|
July 8, 2020
Trends in Indicators of Injection Drug Use, Indian Health Service, 2010-2014 : A Study of Health Care Encounter Data
Mary E Evans, Marissa Person, Brigg Reilley, et al.
Page
of 21